Extended aromatase inhibitor therapy for early breast cancer - Authors' reply

Lancet. 2026 Jan 31;407(10527):495-496. doi: 10.1016/S0140-6736(25)02627-3.

Authors

Jeremy Braybrooke¹, Rosie Bradley¹, Robert Hills²; Early Breast Cancer Trialists' Collaborative Group¹

Affiliations

¹ EBCTCG Secretariat, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
² EBCTCG Secretariat, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK. Electronic address: bc.overview@ndph.ox.ac.uk.

PMID: 41620228
DOI: 10.1016/S0140-6736(25)02627-3

No abstract available

Publication types

Letter